874 — Guangzhou Baiyunshan Pharmaceutical Holdings Co Balance Sheet
0.000.00%
HealthcareBalancedMicro Cap
Annual balance sheet for Guangzhou Baiyunshan Pharmaceutical Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 17,819 | 21,013 | 22,979 | 20,557 | 20,752 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 17,015 | 19,175 | 20,652 | 21,526 | 21,512 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 47,397 | 52,811 | 57,064 | 55,984 | 57,762 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,260 | 5,836 | 6,570 | 7,516 | 7,939 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 59,760 | 66,118 | 74,665 | 78,587 | 81,684 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 29,243 | 32,254 | 37,395 | 36,235 | 38,916 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 33,615 | 37,056 | 42,600 | 43,668 | 45,779 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 26,145 | 29,062 | 32,065 | 34,919 | 35,905 |
| Total Liabilities & Shareholders' Equity | 59,760 | 66,118 | 74,665 | 78,587 | 81,684 |
| Total Common Shares Outstanding |